BABA-W Stock Performance: BABA-W (09988.HK) saw a 5.3% increase, closing at HKD168.3 with a turnover of HKD21.106 billion, while short selling reached $1.95 billion with a ratio of 9.235%.

Qianwen App Growth: The Qianwen app, launched two months ago, surpassed 100 million monthly active users, particularly gaining traction among students and white-collar workers, with a significant product update expected soon.

ALI HEALTH Surge: ALI HEALTH (00241.HK) experienced a notable 15.9% rise, closing at HKD7.58, with a turnover of HKD3.117 billion and short selling amounting to $702.77 million.

DAMAI ENT Performance: DAMAI ENT (01060.HK) increased by 2.1% by midday, with short selling at $19.97 million and a ratio of 18.752%.

Stock Ratings and Price Targets: Various companies including Alibaba, Baidu, and JD.com received "Buy" ratings with specific price targets, while others like Meituan and Tencent were rated "Neutral" or faced declines in stock prices.

Short Selling Data: Significant short selling activity was noted for several stocks, with Meituan and Kuaishou showing high short selling ratios of 20.96% and 19.47%, respectively.

Market Movements: The stock prices of companies like Meituan and Tencent experienced declines, while others like Yixin and IGG saw slight increases.

Analyst Insights: Daiwa maintained a "Buy" rating on Meituan, indicating expectations of widening losses for its Keeta service in the upcoming year.

Implementation Plan for Consumer Goods: Six Chinese ministries have launched a plan to enhance the alignment of supply and demand in consumer goods, aiming to boost consumption amid pressures from insufficient purchasing power.

Government Subsidies: The Chinese government is allocating significant funds for trade-ins of old consumer goods, with RMB150 billion in 2024 and RMB300 billion in 2025, to stimulate short-term demand through national subsidies.

Retail Sales Growth: In October 2025, total retail sales of consumer goods increased by 2.9% year-on-year, although the growth rate showed a slight decline compared to the previous month, indicating ongoing challenges in the consumer market.

Stock Recommendations: China Galaxy Securities has recommended various stocks across sectors, including GUMING and DAMAI ENT in social services, ANTA SPORTS and XTEP INT'L in apparel, and TCL ELECTRONICS in technology, reflecting a focus on the new consumer track.

Stock Performance: DAMAI ENT's stock price fell by 1.163% following its earnings release, with concerns over a slowdown in its domestic ticketing business and increased investments in international markets.

Market Analysis: Goldman Sachs noted that despite the stock volatility, DAMAI ENT's 1HFY26 results were solid, attributing future growth to the expansion of its licensing resources, particularly in retail and consumer markets.

Geopolitical Impact: Citi predicts that escalating Sino-Japanese tensions will have a limited impact on DAMAI ENT, maintaining a Buy rating while reducing the target price from HKD1.3 to HKD1.17.

Short Selling Activity: The company experienced significant short selling activity, with a ratio of 15.824% and a total short selling amount of $29.66 million.

Geopolitical Tensions: Rising tensions between China and Japan have led to the delay of two Japanese films, "Crayon Shin-chan: The Hot Kasukabe Dancers" and "Cells at Work!", as reported by Citi.

Limited Box Office Impact: Despite the delays, Japanese films accounted for only 5% of China's box office last year, suggesting minimal actual impact on overall box office revenue.

Market Sentiment Concerns: The delays may affect market sentiment, particularly regarding investor worries about MAOYAN ENT's potential suspension of the film "Demon Slayer" if tensions worsen.

Target Prices Set: Citi has established target prices for DAMAI ENT at HKD1.4 and MAOYAN ENT at HKD9.3, indicating a cautious outlook amidst the geopolitical climate.